Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 48301-48350 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05475925
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
PHASE1/PHASE2Recruiting
69 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2026
13 conditions1 sponsor36 locations
NCT05200260
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
PHASE2Recruiting
220 participants
Started: Jul 13, 2022 · Completed: Jun 30, 2027
3 conditions2 sponsors9 locations
NCT05045430
PMS Study to Confirm the Ongoing Safety and Performance of Silver II Non-woven Dressing in Chronic and Acute Wounds
NARecruiting
240 participants
Started: Jul 13, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors6 locations
NCT05667857
Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy
NARecruiting
100 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2033
9 conditions2 sponsors2 locations
NCT05384756
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
PHASE1Recruiting
20 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT05463913
Lung Nodule Detection Using Ultra-long FOV PET/CT
PHASE4Recruiting
20 participants
Started: Jul 13, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04940663
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
NARecruiting
120 participants
Started: Jul 13, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05142696
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 13, 2022 · Completed: Mar 23, 2029
1 condition1 sponsor47 locations
NCT05257551
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
N/ARecruiting
50 participants
Started: Jul 13, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors11 locations
NCT05198960
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
PHASE3Recruiting
1,308 participants
Started: Jul 13, 2022 · Completed: Jul 13, 2027
5 conditions1 sponsor42 locations
NCT05708131
Outcomes of Functional Substrate Mapping of Ventricular Tachycardia
N/ARecruiting
70 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2024
1 condition2 sponsors8 locations
NCT05316935
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
PHASE2/PHASE3Recruiting
80 participants
Started: Jul 13, 2022 · Completed: Mar 30, 2027
3 conditions1 sponsor2 locations
NCT06379113
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
PHASE2/PHASE3Recruiting
29 participants
Started: Jul 13, 2022 · Completed: Mar 30, 2027
4 conditions1 sponsor2 locations
NCT05233618
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
PHASE1Recruiting
44 participants
Started: Jul 13, 2022 · Completed: Oct 1, 2026
3 conditions1 sponsor2 locations
NCT05452122
Decoding and Selective Modulation of Human Memory During Awake/Sleep Cycles
NARecruiting
150 participants
Started: Jul 13, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05278351
Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC
PHASE2Recruiting
87 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05362773
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
PHASE1Recruiting
130 participants
Started: Jul 13, 2022 · Completed: May 31, 2027
8 conditions1 sponsor7 locations
NCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert
N/ARecruiting
100 participants
Started: Jul 13, 2022 · Completed: Sep 15, 2026
1 condition1 sponsor1 location
NCT05406830
Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia
NARecruiting
180 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT05381155
Tackling Intrusive Traumatic Memories After Childbirth
NARecruiting
120 participants
Started: Jul 13, 2022 · Completed: Dec 30, 2024
2 conditions1 sponsor2 locations
NCT05469854
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
PHASE1Recruiting
113 participants
Started: Jul 13, 2022 · Completed: Dec 2, 2024
4 conditions1 sponsor1 location
NCT05106608
Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
NARecruiting
60 participants
Started: Jul 13, 2022 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05111223
Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making
NARecruiting
120 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04896931
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
N/ARecruiting
200 participants
Started: Jul 12, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor25 locations
NCT07133789
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders
N/ARecruiting
105 participants
Started: Jul 12, 2022 · Completed: Aug 19, 2025
1 condition1 sponsor1 location
NCT04191460
Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
PHASE2Recruiting
28 participants
Started: Jul 12, 2022 · Completed: Jul 1, 2025
3 conditions1 sponsor1 location
NCT05284552
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
PHASE2Recruiting
40 participants
Started: Jul 12, 2022 · Completed: Dec 31, 2026
1 condition5 sponsors8 locations
NCT05487170
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
PHASE1/PHASE2Recruiting
32 participants
Started: Jul 12, 2022 · Completed: Sep 1, 2025
2 conditions1 sponsor5 locations
NCT05165407
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
PHASE2Recruiting
30 participants
Started: Jul 12, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor2 locations
NCT05153967
Cooperative Assessment of Late Effects for SCD Curative Therapies
N/ARecruiting
750 participants
Started: Jul 12, 2022 · Completed: Feb 28, 2026
4 conditions6 sponsors5 locations
NCT05402033
Cancer Clinical Trials Financial Reimbursement Program
N/ARecruiting
1,200 participants
Started: Jul 12, 2022 · Completed: Jun 1, 2027
1 condition2 sponsors1 location
NCT05305794
"Effect of Weekly GLP1 Agonist Treatment in double Diabetes"
PHASE3Recruiting
76 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05752604
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
N/ARecruiting
3,000 participants
Started: Jul 12, 2022 · Completed: Mar 8, 2042
1 condition1 sponsor1 location
NCT06456411
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
NARecruiting
430 participants
Started: Jul 12, 2022 · Completed: Jul 12, 2026
3 conditions1 sponsor1 location
NCT05464251
Prospective Analysis of Spinal Epidural Abscess
N/ARecruiting
200 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05452226
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
NARecruiting
8 participants
Started: Jul 12, 2022 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05474378
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
PHASE1Recruiting
39 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05795894
Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
N/ARecruiting
10 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2024
2 conditions1 sponsor1 location
NCT05594797
Human BCMA Targeted T Cells Injection(BCMA CAR-T)for Subjects With R/R MM
PHASE2Recruiting
100 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2027
1 condition3 sponsors2 locations
NCT06579573
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
PHASE3Recruiting
15 participants
Started: Jul 12, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor25 locations
NCT05989178
Prospective Recurrent Pregnancy Loss Registry
N/ARecruiting
3,000 participants
Started: Jul 12, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05408143
An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical Complexity
NARecruiting
300 participants
Started: Jul 12, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT05747365
Role of Endocrine Disruptors in Thyroid Cancer
N/ARecruiting
222 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05245695
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
N/ARecruiting
1,200 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor10 locations
NCT05419089
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
PHASE2Recruiting
83 participants
Started: Jul 12, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor2 locations
NCT05263596
SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine
NARecruiting
120 participants
Started: Jul 11, 2022 · Completed: Oct 30, 2024
3 conditions1 sponsor1 location
NCT05574868
Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)
NARecruiting
177 participants
Started: Jul 11, 2022 · Completed: May 21, 2026
1 condition1 sponsor3 locations
NCT05452889
PET Image in PAH Patients
EARLY_PHASE1Recruiting
71 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05536531
NMES Role to Prevent Respiratory Muscle Weakness in Critically Ill Patients and Its Association to Changes in Myokines.
NARecruiting
32 participants
Started: Jul 11, 2022 · Completed: Feb 28, 2025
3 conditions1 sponsor1 location
NCT06800469
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NARecruiting
30 participants
Started: Jul 11, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor1 location